Patent · US Active

Saponin adjuvant and evaluation method thereof

US12221461B2 · kind B2 · utility

0Cited by
1References
15Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMar 27, 2019
Grant dateFeb 11, 2025
Priority date
Expiry dateJun 15, 2042

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG01N2030/8886
  • WIPO fieldMeasurement
  • WIPO sectorInstruments

Abstract

The present disclosure is related to the six isomer structures (OBI-821-1990-V1A, OBI-821-1990-V1B, OBI-821-1990-V2A, OBI-821-1990-V2B, OBI-821-1858-A, and OBI-821-1858-B) of isolated OBI-821 adjuvant and the method for evaluating the quality thereof. The method of the present disclosure adopts hydrophilic interaction liquid chromatography (HILIC) and reverse phase high performance liquid chromatography (RP-HPLC) either alone or in tandem and is able to separate the isomers of OBI-821 adjuvant in the consequent chromatography. Accordingly, the quality of OBI-821 adjuvant can be further evaluated.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.